CN Patent

CN105658238A — 用于在预防和/或治疗多动性运动障碍中使用的治疗剂

Assigned to Som Innovation Biotech SA · Expires 2016-06-08 · 10y expired

What this patent protects

本发明涉及具有式(IA)的(RS)-[2-(3，4-二甲氧基苯基)乙基][2-羟基-3-(3-甲基苯氧基)丙基]胺或其药用盐用于配制药物组合物的用途，其可用于预防和/或治疗与亨廷顿病、威尔逊病、图雷特综合征、下肢不宁综合征和迟发性运动障碍相关的多动性运动障碍。

USPTO Abstract

本发明涉及具有式(IA)的(RS)-[2-(3，4-二甲氧基苯基)乙基][2-羟基-3-(3-甲基苯氧基)丙基]胺或其药用盐用于配制药物组合物的用途，其可用于预防和/或治疗与亨廷顿病、威尔逊病、图雷特综合征、下肢不宁综合征和迟发性运动障碍相关的多动性运动障碍。

Drugs covered by this patent

valbenazine-tosylate (VALBENAZINE TOSYLATE)

Patent Metadata

Patent number: CN105658238A
Jurisdiction: CN
Classification: —
Expires: 2016-06-08
Drug substance claim: No
Drug product claim: No
Assignee: Som Innovation Biotech SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.